Modulatory effect of the adrenergic system upon fibroblast proliferation: Participation of β3-adrenoceptors

Autonomic and Autacoid Pharmacology

Volumn 22, Issue 3, 2002, Pages 177-186

  Anesini, C ^a   Borda, E ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [(2 HYDROXY 3 PHENOXYPROPYL)AMINO]ETHOXY] N (2 METHOXYETHYL)PHENOXYACETAMIDE; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUTOXAMINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC AMP; DOBUTAMINE; ISOPRENALINE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PRACTOLOL; PROPRANOLOL; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; SALBUTAMOL; STAUROSPORINE; TRIFLUOPERAZINE;

ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE EXPRESSION; LIGAND BINDING; MOUSE; NONHUMAN;

ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ADRENERGIC BETA-3 RECEPTOR AGONISTS; ADRENERGIC BETA-3 RECEPTOR ANTAGONISTS; ANIMALS; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLASTS; MICE; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0036616170     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1474-8673.2002.00261.x     Document Type: Article

References (62)

1. BILLIAU, A., CASSIMAN, J.J., WILLEMS, D., VERHELST, M. & HEREMANS, H. (1975). In vitro' cultivation of human tumor tissues. Oncology, 31, 257-272.
2. BLIN, N., NAHMIAS, C., DRUMARE, M.F. & STROSBERG, A.D. (1994). Mediation of most atypical effects by species homologues of the beta 3 adrenoceptors. Br. J. Pharmacol., 112, 911-919.
3. BLUE, D.R., BOND, R.A., ADHAM, N., DELMONDO, R., MICHEL, A.D., EGLEN, R., WHITHING, R.L. & CLARKE, D.E. (1990). Interaction of dihydroalprenolol and cyanopindolol with atypical β adrenoceptors in Guinea-pig ileum. J. Pharmacol. Exp. Ther., 252, 1043-1042.
4. BOND, D.R. & CLARKE, D.E. (1998). Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the α and β subtypes. Br. J. Pharmacol., 85, 723-734.
5. BRONNIKOV, G., HOUSTEK, J. & NEDERGAARD, J. (1992). β adrenergic, cAMP-mediated stimulation of proliferation of brown fat cells in primary culture. J. Biol. Chem., 267, 2006-2013.
6. BRONNIKOV, G.E., ZHANG, S.J., CANNON, B. & NEDERGAARD, J. (1999). A dual component analysis explains the distinctive kinetics of cAMP accumulation in brown adipocytes. J. Biol., 274, 37770-37780.
7. 2+-dependent cAMP accumulation by phorbol myristate acetate. J. Biol. Chem., 257, 6758-6765.
8. BROWN, B., ALBANO, J., EKINS, R. & SGHERZI, A. (1971). A simple and sensitive methods for measurement of adenosine 3′,5′ cyclic monophosphate. Biochem. J., 121, 561-562.
9. CAZAUX, C., STERIN BORDA, L., GORELIK, G. & CREMASCHI, G. (1995). Down regulation of β adrenoceptor induced by mitogen activation of intracellular signaling events in lymphocytes. FEBS Lett., 364, 120-124.
10. CHAUDHRY, A., MACKENZIE, R.G., GEORGIC, L.M. & GRANNEMAN, J.G. (1994). Differential interaction of beta 1 and beta 3 adrenergic receptors with Gi in rat adipocytes. Cell Signal, 6, 457-465.
11. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
12. COFFEY, R. & HADDEN, J. (1985). Neurotransmitters hormones and cyclic nucleotides in lymphocytes regulation. Fed Proc., 44, 112-117.
13. COLOMBO, F., NOEL, J., MAYERS, P., MERCIER, I. & CALDERONE, A. (2001). Beta adrenergic stimulation of rat cardiac fibroblasts promote protein synthesis via the activation of phosphatidylinositol 3 kinase. J. Mol. Cell. Cardiol., 33, 1049-1051.
14. 2+ uptake by isolated brown adipocytes. Possible involvement of mitochondria. J. Biol. Chem., 263, 10574-10582.
15. CREMASCHI, G., FISHER, P. & BOEGE F. (1991). β adrenoceptor distribution in murine lymphoid cell line. Immunopharmacology, 22, 195-206.
16. CREMASCHI, G.A., GENARO, A.M., CAZAUX, C.A., ANESINI, C., WALD, M., BORDA, T. & STERIN BORDA, L. (2000). Altered beta adrenoceptor function associated to protein kinase C activation in hyperproliferative T lymphocyte. J. Neuroimmunol., 110, 57-65.
17. CREMASCHI, G.A., MIGUEL, S., CAZAUX, C.A. & STERIN BORDA, L. (1994). Increased proliferative activity, loss of β adrenergic receptor function and class I histocompatibility complex antigen surface expression in a modified lymphoma cell line. Cell. Signalling, 6, 783-792.
18. 2 adrenergic receptor to different G proteins by protein kinase A. Nature, 390, 88-89.
19. DUMONT, J.E., JAUNIAUX, J.C. & ROGER, P.P. (1989). The cyclic AMP-mediated stimulation of cell proliferation. Trends. Biochem. Sci., 14, 67-71.
20. DUNNETT, C.W. (1964). New table of multiple comparisons with a control. Biometrics, 20, 482-491.
21. 3 adrenergic receptors. Science, 245, 1118-1121.
22. EMORINE, L., BLIN, N. & STROSBERG, A.D. (1994). The human beta 3 adrenoceptors: the search for a physiological function. Trends Pharmacol. Sci., 15, 3-7.
23. 125I) iodocyanopindolol, a new ligand for β adrenoceptor: identification and quantitation of subclasses of β adrenoceptors in guinea-pigs. NaunznSchmiedeberg's Arch. Pharmacol., 317, 277-285.
24. FEVE, B., EMORINE, L.J., LASMIER, F., BLIN, N., BAUDE, B., NAHMIAS, C., STROSBERG, A.D. & PIRAULT, J. (1991). Atypical β adrenergic receptor in 3T3 F442 A adipocytes pharmacological and molecular relationship with the human β3 adrenergic receptor. J. Biol. Chem., 266, 20329-20336.
25. FRESHNEY, R. (1994). Disaggregation of the tissue and primary culture. In: Culture of Animal Cells, Manual of Basic Techniques, 3rd Edn (Eds WILEY, Y; LISS, A), Editorial, pp. 99-102. ARL, NY.
26. GAUTHIER, C., TAVERNIER, G., CHARPENTIER, F., LANGIN, D. & LE MAREC, H. (1996). Functional beta 3-adrenoceptor in the human heart. J. Clin. Invest, 98, 556-562.
27. 3. adrenergic receptors. Mol. Pharmacol., 40, 895-899.
28. GRIMM, W. & MARKS, F. (1974). Effect of tumor-promoting phorbol esters on the normal and the isoproterenol-elevated level of adenosine 3′,5′-cyclic monophosphate in mouse epidermis in vivo. Cancer Res., 34, 3129-3134.
29. GROWCOTT, J.W., CAMPBELL, W., HOLLOWAY, B. & MAINWARING, S. (1993). Evaluation of ICI D7114 a putative stimulant of brown adipocytes on histamine-contracted guinea-pig ileum. Br. J. Pharmacol., 109, 1212-1218.
30. HOUSLAY, M. (1991). Crosstalk: a pivotal role of protein kinase C in modulating relationship between signal transduction pathway. Eur. J. Biochem., 195, 9-27.
31. ISAKOV, N., GALRON, D., MUSTELIN, T., PETTIT, G.R. & ALTMAN, A. (1993). Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C. J. Immunol., 150, 1195-1204.
32. 3 adrenergic receptor mRNA in man. J. Clin. Invest., 91, 34-349.
33. LEICHT, M., GREIPEL, N. & ZIMMER, H. (2000). Comitogenic effect of catecholamines on rat cardiac fibroblast in culture. Cardiovas. Res., 48, 274-284.
34. MANNIER, D.H., SGHELTON, R.C., ELLIS, T.C., PETRSON, C.S., EIRING, A. & SULSER, F. (2000). Human fibroblast as a relevantt model to study signal transduction in affective disorders. J. Affect. Disord., 61, 51-8.
35. 3 adrenoceptor) in the rat distal colon in vitro. Br. J. Pharmacol., 101, 569-574.
36. MCLAUGHLIN, D.P. & MCDONALD, A. (1991). Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus evidence for an atypical β adrenoceptor. Br. J. Pharmacol., 103, 1351-1356.
37. MIZUNO, K., KANDA, Y., KUROKI, Y., TOMIYAMA, K. & WATANABE, Y. (1999). Phosphorylation of extracellular signal-regulated kinases 1 and 2 in 3T3 L1 adipocytes by stimulation of beta (3)-adrenoceptor. Eur. J. Pharmacol., 385, 63-9.
38. NISHIMURA, K., TAMAOKI, J., AOSHIBA, K., ISONO, K. & NAGAI, A. (1998). Effect of salbutamol on proliferation of human bronchial epithelial cells: role of MAP kinase. Nihon Koyiki Gakkai Zasshi, 36, 428-432.
39. NISHIZUKA, Y. (1992). Intracellular signalling by hydrolisis of phospholipids and activation of protein kinase C. Science, 258, 607-614.
40. OLASHAW, N.E. & PLEDGER, W.J. (1988). Cellular mechanisms regulating proliferation. Adv. Second Messenger Phosphoprotein Res., 22, 139-173.
41. PASTAN, I.H., JOHNSON, G.S. & ANDERSON, W.B. (1975). Role of cyclic nucleotides in growth control. Annu. Rev. Biochem., 44, 491-522.
42. PATYA, M., STENZEL, K.H. & NOVOGRODSKY, T. (1985). Differential effects of tumor promoters on cAMP production: inhibition of receptor-mediated and potentiation of cholera toxin-mediated stimulation. Biochem. Biophys. Res. Commun., 133, 904-920.
43. ROBBERECHT, P., DE NEEF, P., BUSCAIL, L. & CHRISTOPHE, J. (1989). The phorbol ester TPA stimulates the expression of functional beta-adrenoceptors in human T lymphocytes Molt 3. Biochem. J., 261, 959-963.
44. ROCHETTE-EGLY, C., CHOUROULINKOV, & CASTAGNA, M. (1979). Cyclic nucleotide levels in rat embryo fibroblast treated with tumor promoting phorbol diester. J. Cyclic Nucleotide Res., 5, 385-395.
45. ROSZMAN, T. & BROOK, W. (1988). Signaling pathway of the neuroendocrine immuno network. Prog. Allergy, 43, 1240-1259.
46. SCATCHARD, S. (1949). The attractions of protein for small molecules and ions. Ann. Ny. Acad. Sci., 51, 660-672.
47. SCHULLER, H.M., POTER, B. & RIECHERT, A. (2000). Beta-adrenergic modulation of NNK induced lung carcinogenesis in hamster. J. Cancer. Res. Clin. Oncol., 126, 624-630.
48. SHEPPARD, J.R., GORMUS, Q. & RODBELL, M. (1974). A highly sensitive adenylate cyclase assay. Anal. Biochem., 58, 541-548.
49. SMITH, R.J., JUSTEN, J.M., MCNAB, H.R., ROSEMBLOOM, C.L., STEELE, A.N., DETMERS, P.A., ANDERSON, D.S. & MANNING, A.M. (1996). U73122: a potent inhibitor of human polimorphonuclear neutrophils adhesion on biological surfaces and adhesion related effector functions. J. Pharmacol. Exp. Ther., 278, 320-329.
50. STERIN BORDA, L., VILA ECHAGUE, A., PEREZ LEIROS, C., GENARO, A. & BORDA, E. (1995). Endogenous nitric oxide signalling system and the cardiac muscarinic acetilcholinic receptor-inotropic response. Br. J. Pharmacol., 115, 1525-1531.
51. STROSBERG, A.D. & PIETRI-ROUXEL, F. (1996). Function and regulation of beta 3 adrenoceptor. Trends Pharmacol. Sci., 17, 373-381.
52. TAKEMURA, H., HATTA, S., YAMADA, K. & OHSHIKA, H. (1995). Beta adrenergic receptor mediated calcium mobilization in human jurkat T cell line. Life Sci., 56, 1443-1454.
53. TAMAOKI, T., NOMOTO, H., TAKAHASHI, I., KATO, Y., NOSIMOTO, M. & TOMITA, F. (1986). Staurosporine a potent inhibitor of phospholipid/calcium dependent protein kinase. Biochem. Biophys. Res. Commun., 135, 397-402.
54. TOVEY, M.G., ROCHETTE-EGLY, C. & CASTAGNA, M. (1980). Correlation between growth rate cell density and intracellular concentrations of cyclic nucleotides in chemostat culture of mouse L1210 cells. J. Cell. Physiol., 105, 363-367.
55. TSENG, Y.T., KOFEL, R., STABILA, J.P., MCGONNIGAL, B.G., NGUYEN, T.T., GRUPPUSO, P.S.A. & PADBURY, J.F. (2001). Beta adrenergic receptors (beta AR) regulate cardiomyocyte proliferation during early postnatal life. FASEB J., 15, 1921-1926.
56. VAN DER VLIET, A., RADEMAKER, B. & BAST, A. (1990). A β adrenoceptor with atypical characteristics is involved in the relaxation of the rat small intestine. J. Pharmacol. Exp. Ther., 255, 218-226.
57. WADHWA, R., IKAWA, Y. & P., SUGIMOTO, Y. (1991). Natural and conditional ageing of mouse fibroblast: genetic vs epigenetic control. Biochem. Biophys. Res. Commun., 178, 269-275.
58. WEDDLE, D.L., TITHOFF, P., WILLIAMS, M. & SCHULLER, H.M. (2001). Beta adrenergic growth regulation of human cancer cell line derived from pancreatic ductal carcinomas. Carcinogenesis, 22, 473-479.
59. WERNER, C., POLLER, V. & BRODDE, O. (1997). Chronic terbutaline treatment desensitizes beta adrenergic inhibition of lymphocyte activation in healthy volunteers. J. Auton. Pharmacol., 17, 237-242.
60. YU, H.J., MA, H. & GREEN, R.D. (1993). Calcium entry via L tyoe calcium channel acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes. Mol. Pharmacol., 44, 689-693.
61. ZANKER, B., MARX, S., STROM, T.B. & KOHLER, H. (1994). The immunesuppresive effects of verapamil upon mitogen activated and alloantigen inducible human cytotoxic T lymphocytes. Int. J. Immunpharmacol., 16, 507-517.
62. ZHOU, P., GORZNYSHI, T., DOWJAT, W.K., RABIN, R. & ZALESKI, M.B. (1989). In vitro proliferation of murine spleen cells: inhibition by monoclonal antibodies to L3T4 and Lyt-2 T cell markers on intracellular cyclic adenosine monophosphate. Exp. Cell Biol., 57, 346.